Gainers
- Arcturus Therapeutics ARCT stock moved upwards by 29.05% to $44.73 during Tuesday's regular session. As of 12:35 EST, Arcturus Therapeutics's stock is trading at a volume of 4.1 million, which is 818.75% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion.
- Translate Bio TBIO stock increased by 29.02% to $37.61. Trading volume for Translate Bio's stock is 42.0 million as of 12:35 EST. This is 4465.9% of its average full-day volume over the last 100 days. The company's market cap stands at $2.8 billion.
- Applied DNA Sciences APDN shares increased by 27.25% to $6.91. The current volume of 2.2 million shares is 357.67% of Applied DNA Sciences's average full-day volume over the last 100 days (last updated at 12:35 EST). The company's market cap stands at $51.7 million.
- NeuroMetrix NURO shares rose 20.46% to $15.8. The current volume of 3.8 million shares is 50.25% of NeuroMetrix's average full-day volume over the last 100 days (last updated at 12:35 EST). The market value of their outstanding shares is at $88.9 million.
- Outlook Therapeutics OTLK shares rose 16.37% to $2.63. As of 12:35 EST, this security is trading at a volume of 94.0 million shares, making up 10449.3% of its average full-day volume over the last 100 days. The company's market cap stands at $456.6 million.
- ATI Physical Therapy ATIP shares moved upwards by 13.59% to $4.26. Trading volume for ATI Physical Therapy's stock is 5.7 million as of 12:35 EST. This is 223.97% of its average full-day volume over the last 100 days. The company's market cap stands at $883.0 million.
Losers
- Neuronetics STIM stock decreased by 40.87% to $7.71 during Tuesday's regular session. Neuronetics's stock is trading at a volume of 3.1 million shares as of 12:35 EST. This is 653.26% of its average full-day volume over the last 100 days. The company's market cap stands at $198.4 million. As per the news, the Q2 earnings report came out today.
- Kiniksa Pharmaceuticals KNSA stock decreased by 21.48% to $12.74. Trading volume for Kiniksa Pharmaceuticals's stock is 1.5 million as of 12:35 EST. This is 370.73% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $870.8 million. As per the news, the Q2 earnings report came out today.
- Scholar Rock Holding SRRK shares fell 17.54% to $28.32. As of 12:35 EST, this security is trading at a volume of 323.6K shares, making up 124.01% of its average full-day volume over the last 100 days. The company's market cap stands at $974.6 million.
- SeaSpine Holdings SPNE shares fell 15.61% to $16.77. The current volume of 317.9K shares is 180.19% of SeaSpine Holdings's average full-day volume over the last 100 days (last updated at 12:35 EST). The market value of their outstanding shares is at $556.1 million. As per the press release, Q2 earnings came out yesterday.
- SI-BONE SIBN stock decreased by 15.07% to $25.7. Trading volume for SI-BONE's stock is 689.9K as of 12:35 EST. This is 278.07% of its average full-day volume over the last 100 days. The company's market cap stands at $843.7 million. As per the news, the Q2 earnings report came out yesterday.
- Infinity Pharmaceuticals INFI shares decreased by 13.49% to $2.54. As of 12:35 EST, Infinity Pharmaceuticals's stock is trading at a volume of 9.7 million, which is 153.79% of its average full-day volume over the last 100 days. The company's market cap stands at $224.9 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in